Peptides for blood sugar and metabolic health
Type 2 diabetes, insulin sensitivity and cardiovascular risk. This is the best-evidenced use case in the entire catalog, because it is where the pharmaceutical industry ran the large trials.
Ranked by strength of evidence
- S+Semaglutide
Improves blood-sugar control and lowers cardiovascular risk in type 2 diabetes
Read the evidence → - S+
- S+Mazdutide
Improves blood-sugar control in adults with type 2 diabetes
Approved for diabetes in China. Beat dulaglutide head-to-head; the semaglutide comparison is not yet published.
Read the evidence → - S+Semaglutide
Reduces major cardiovascular events in adults with overweight/obesity and established heart disease
Read the evidence → - S
- BNAD+ (and precursors NMN / NR)
Improves metabolic health (glucose, lipids, insulin sensitivity) in people
Read the evidence →
The honest read
Every top grade on this page belongs to a prescription medicine studied in tens of thousands of people. If metabolic health is the goal, this is the part of the category where the evidence is genuinely overwhelming — and all of it runs through a prescriber.
Looking at a different goal? Browse all use cases, or get every peptide’s grade on one page.